Laird Norton Wetherby Wealth Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604K | Buy |
+7,724
| New | +$604K | 0.03% | 505 |
|
|
2024
Q4 | $617K | Sell |
8,336
-530
| -6% | -$39.2K | 0.03% | 468 |
|
|
2024
Q3 | $585K | Sell |
8,866
-2,460
| -22% | -$162K | 0.03% | 507 |
|
|
2024
Q2 | $1.05M | Sell |
11,326
-251
| -2% | -$23.2K | 0.05% | 343 |
|
|
2024
Q1 | $1.11M | Buy |
11,577
+226
| +2% | +$21.6K | 0.05% | 339 |
|
|
2023
Q4 | $866K | Sell |
11,351
-95
| -0.8% | -$7.24K | 0.05% | 386 |
|
|
2023
Q3 | $793K | Sell |
11,446
-3,216
| -22% | -$223K | 0.05% | 390 |
|
|
2023
Q2 | $1.38M | Sell |
14,662
-675
| -4% | -$63.7K | 0.07% | 271 |
|
|
2023
Q1 | $1.27M | Buy |
15,337
+2,547
| +20% | +$211K | 0.07% | 282 |
|
|
2022
Q4 | $954K | Sell |
12,790
-858
| -6% | -$64K | 0.06% | 338 |
|
|
2022
Q3 | $1.13M | Buy |
13,648
+1,651
| +14% | +$136K | 0.08% | 256 |
|
|
2022
Q2 | $1.14M | Sell |
11,997
-921
| -7% | -$87.6K | 0.08% | 266 |
|
|
2022
Q1 | $1.52M | Sell |
12,918
-333
| -3% | -$39.2K | 0.09% | 220 |
|
|
2021
Q4 | $1.72M | Buy |
13,251
+721
| +6% | +$93.4K | 0.1% | 194 |
|
|
2021
Q3 | $1.42M | Buy |
12,530
+265
| +2% | +$30K | 0.09% | 214 |
|
|
2021
Q2 | $1.27M | Buy |
12,265
+621
| +5% | +$64.3K | 0.08% | 241 |
|
|
2021
Q1 | $973K | Sell |
11,644
-514
| -4% | -$43K | 0.07% | 258 |
|
|
2020
Q4 | $1.11M | Buy |
12,158
+437
| +4% | +$39.9K | 0.08% | 246 |
|
|
2020
Q3 | $935K | Sell |
11,721
-355
| -3% | -$28.3K | 0.08% | 233 |
|
|
2020
Q2 | $834K | Buy |
12,076
+1,549
| +15% | +$107K | 0.08% | 249 |
|
|
2020
Q1 | $662K | Sell |
10,527
-426
| -4% | -$26.8K | 0.07% | 256 |
|
|
2019
Q4 | $852K | Buy |
10,953
+333
| +3% | +$25.9K | 0.08% | 249 |
|
|
2019
Q3 | $779K | Buy |
10,620
+720
| +7% | +$52.8K | 0.08% | 267 |
|
|
2019
Q2 | $610K | Buy |
9,900
+81
| +0.8% | +$4.99K | 0.07% | 330 |
|
|
2019
Q1 | $626K | Buy |
9,819
+1,011
| +11% | +$64.5K | 0.08% | 305 |
|
|
2018
Q4 | $450K | Buy |
8,808
+2,268
| +35% | +$116K | 0.06% | 357 |
|
|
2018
Q3 | $379K | Sell |
6,540
-135
| -2% | -$7.82K | 0.05% | 435 |
|
|
2018
Q2 | $323K | Buy |
6,675
+150
| +2% | +$7.26K | 0.04% | 450 |
|
|
2018
Q1 | $303K | Buy |
6,525
+792
| +14% | +$36.8K | 0.04% | 479 |
|
|
2017
Q4 | $215K | Buy |
5,733
+69
| +1% | +$2.59K | 0.03% | 580 |
|
|
2017
Q3 | $206K | Buy |
5,664
+447
| +9% | +$16.3K | 0.03% | 559 |
|
|
2017
Q2 | $206K | Buy |
+5,217
| New | +$206K | 0.04% | 521 |
|
|
2016
Q4 | – | Sell |
-5,871
| Closed | -$236K | – | 531 |
|
|
2016
Q3 | $236K | Buy |
+5,871
| New | +$236K | 0.05% | 448 |
|